E
Elliott M. Antman
Researcher at Brigham and Women's Hospital
Publications - 738
Citations - 187175
Elliott M. Antman is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 161, co-authored 716 publications receiving 179462 citations. Previous affiliations of Elliott M. Antman include Duke University & Katholieke Universiteit Leuven.
Papers
More filters
Journal ArticleDOI
Determinants of Coronary Blood Flow After Thrombolytic Administration
C. Michael Gibson,Sabina A. Murphy,Ian B. A. Menown,Rafael F. Sequeira,Robert M. Greene,Frans Van de Werf,Marc J. Schweiger,Magdi Ghali,Martin J. Frey,K. Ryan,Susan J. Marble,Robert P. Giugliano,Elliott M. Antman,Christopher P. Cannon,Eugene Braunwald +14 more
TL;DR: Lumen geometry is not the sole determinant of coronary blood flow at 90 min following thrombolytic administration, and other variables such as the location of the culprit artery, the duration of patency, a pulsatile flow pattern and thrombus are also related to slower flow.
Journal ArticleDOI
Fibrinolysis for acute myocardial infarction: the future is here and now.
TL;DR: The increase in systemic bleeding and apparent excess of intracranial hemorrhage among STEMI patients over 75 years has led to reassessment of the suitability of combination reperfusion with IV GP IIb/IIIa inhibitors and reduced dose fibrinolysis.
Journal ArticleDOI
Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B.
Milenko J. Tanasijevic,Christopher P. Cannon,Elliott M. Antman,Donald R. Wybenga,George A. Fischer,Christine Grudzien,C. Michael Gibson,James W. Winkelman,Eugene Braunwald +8 more
TL;DR: Serum marker determinations at baseline and 60-min after thrombolysis may permit rapid triage of patients receiving thromBOlytic therapy by ruling out IRA occlusion and early invasive interventions to establish IRA patency may not be necessary in this group.
Journal ArticleDOI
The Search for Replacements for Unfractionated Heparin
TL;DR: Combinations of antithrombins shown and antiplatelet agents are effective in reducing propensity to thrombus formation at the site of a disrupted vulnerable plaque.
Journal ArticleDOI
Prognostic Performance of a High-Sensitivity Cardiac Troponin I Assay in Patients with Non–ST-Elevation Acute Coronary Syndrome
Erin A. Bohula May,Marc P. Bonaca,Petr Jarolim,Elliott M. Antman,Eugene Braunwald,Robert P. Giugliano,L. Kristin Newby,Marc S. Sabatine,David A. Morrow +8 more
TL;DR: Application of this hs-cTnI assay identified a clinically relevant higher risk of recurrent events among patients with NSTE-ACS, even at very low troponin concentrations.